Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-016267
- form_type
- 8-K
- ticker
- CMII
- cik
- 0002088805
- company_name
- Columbus Circle Capital Corp II
- filed_at
- 2026-02-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:37.233972+00:00
- generated_at
- 2026-05-16T02:51:13.989671+00:00
- sec_items
- ["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-016267
- json_url
- https://secwatch.observer/filing/0001213900-26-016267.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-016267.md
- text_url
- https://secwatch.observer/filing/0001213900-26-016267.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/2088805/000121390026016267/0001213900-26-016267-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/2088805/000121390026016267/ea0277019-8k_columbus2.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
c594889846d622ec2bb81ac491eb2a8396d9b4ac
Columbus Circle Capital Corp II: Filed amended and restated memorandum and articles of association effective February 10, 2026, in connection with the IPO (effective 2026-02-10).
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
2b820094189ddaf50a852ab7ab0b446172553fd3
Columbus Circle Capital Corp II entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-10).
An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
38c53e878713c0e43f73886a37f1764b1bf677cb
Columbus Circle Capital Corp II entered into Underwriting Agreement with Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Clear Street LLC, as representatives of the several underwriters (effective 2026-02-10).
An Underwriting Agreement, dated February 10, 2026, by and between the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Clear Street LLC, as representatives of the several underwriters
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
44f8d68a2c5c51814a7504096eee368b415c7636
Columbus Circle Capital Corp II entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-10).
A Warrant Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
5d0fc7f55227182792c00ca7460a9f7c42d48331
Columbus Circle Capital Corp II entered into Registration Rights Agreement with certain security holders (effective 2026-02-10).
● A Registration Rights Agreement, dated February 10, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
6afe8fd6f239d795a941e71ac244fc256c4f3e01
Columbus Circle Capital Corp II entered into Sponsor Private Placement Units Purchase Agreement with Columbus Circle 2 Sponsor Corporation LLC (effective 2026-02-10).
A Private Placement Units Purchase Agreement, dated February 10, 2026 (the “ Sponsor Private Placement Units Purchase Agreement ”), by and between the Company and Columbus Circle 2 Sponsor Corporation LLC, a Delaware limited liability company (the “ Sponsor ”)
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
SAGU
Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE
Shreya Acquisition Group
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
Comparable filing
On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
Comparable filing
On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.
Filing page
SEC filing
CLRB
Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data
Cellectar Biosciences, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 8.01, 9.01
same event type: other_material
similar materiality
This filing
An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee
Comparable filing
pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”
Filing page
SEC filing
PSEC
Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares
PROSPECT CAPITAL CORP
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 5.03, 9.01
same event type: other_material
similar materiality
This filing
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
Comparable filing
On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.
Filing page
SEC filing
ADT
Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan
ADT Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.02, 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On February 10, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on February 10, 2026.
Comparable filing
On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.
Filing page
SEC filing
TPST
Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73
Tempest Therapeutics, Inc.
June 1, 2026, 7:13 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee
Comparable filing
On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock
Filing page
SEC filing
KRMN
Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds
Karman Holdings Inc.
June 1, 2026, 5:28 PM ET
other_material
Items 1.01, 7.01, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 8.01, 9.01
same event type: other_material
similar materiality
This filing
An Investment Management Trust Agreement, dated February 10, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee
Comparable filing
On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.